[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"fluid-responsiveness\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:fluid-responsiveness":27},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,8,0,[8,41,71,104,146,162,189,215],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":18,"enrollmentInfo":19,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":23,"conditions":24,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":29,"lastUpdatePostDateStruct":30,"startDateStruct":33,"completionDateStruct":35,"leadSponsor":37,"locationsCount":40},"100591499","pvi-predictors-in-laparoscopic-hysterectomy-100591499",false,"NCT06981221","PVI Predictors in Laparoscopic Hysterectomy","Predictors of Pleth Variability Index During Laparoscopically Assisted Vaginal Hysterectomy","Inclusion Criteria:\n\n* adult females aged 19-70 years (American Society of Anesthesiologists physical status I-III) scheduled for elective LAVH.\n\nExclusion Criteria:\n\n* emergency surgery, severe cardiac or pulmonary disease, renal failure, pregnancy, or conditions contraindicating fluid administration. Participants were consecutively recruited during preoperative consultations.","FEMALE","19 Years","70 Years",{"count":20,"type":21},50,"ESTIMATED","OBSERVATIONAL","This observational study investigates the predictors of Pleth Variability Index (PVI) changes in euvolemic patients undergoing laparoscopic-assisted vaginal hysterectomy (LAVH). The primary objective is to quantify changes in PVI (ΔPVI) across six intraoperative time points associated with positional shifts. Secondary objectives include identifying key predictors of significant PVI change (ΔPVI ≥ 5%), such as passive leg raising, Trendelenburg position, body mass index (BMI), and intraabdominal pressure. Additional variables including perfusion index, mean arterial pressure, bispectral index, skin temperature, age, and anesthetic agent will be evaluated as potential modulators. Findings aim to support individualized fluid management strategies in LAVH.",[25,26,27],"Hysterectomy","PVI","Fluid Responsiveness","RECRUITING","2026-06-24",{"date":31,"type":32},"2026-06-29","ACTUAL",{"date":34,"type":21},"2026-07-01",{"date":36,"type":21},"2026-08-20",{"name":38,"class":39},"Wonkwang University Hospital","OTHER",1,{"id":42,"slug":43,"hasResults":11,"nctId":44,"briefTitle":45,"officialTitle":46,"acronym":4,"eligibilityCriteria":47,"healthyVolunteers":11,"sex":48,"minAge":49,"maxAge":4,"enrollmentInfo":50,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":52,"conditions":53,"keywords":56,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":62,"lastUpdatePostDateStruct":63,"startDateStruct":65,"completionDateStruct":67,"leadSponsor":69,"locationsCount":40},"100634974","prediction-of-fluid-responsiveness-using-the-femoral-vein-to-artery-diameter-ratio-100634974","NCT07546656","Prediction of Fluid Responsiveness Using the Femoral Vein-to-Artery Diameter Ratio","Prediction of Fluid Responsiveness Using the Femoral Vein-to-Artery Diameter Ratio: A Prospective Observational Study","Inclusion Criteria:\n\n* Adult patients aged 18 years or older\n* Admission to the intensive care unit where the study is being conducted\n* Receiving invasive mechanical ventilation\n* Clinical indication for a fluid challenge due to acute circulatory failure or shock, as determined by the responsible intensive care physician\n* PiCCO monitoring already in place as part of routine clinical care\n* Clinical conditions allowing collection of pre- and post-fluid challenge cardiac index and ultrasonographic measurements\n* Technical feasibility of femoral vein and femoral artery diameter measurements by ultrasonography\n\nExclusion Criteria:\n\n* Age younger than 18 years\n* Failure to obtain written informed consent from the patient or legally authorized representative before enrollment\n* Absence of PiCCO monitoring as part of routine clinical care or no clinical plan for fluid challenge\n* Inability to complete pre- and post-fluid challenge measurements (e.g., early death, urgent surgery, transfer)\n* Local conditions preventing reliable femoral ultrasonographic assessment, including open wound, infection, dressing, major anatomic obstacle, poor image quality, known femoral vein thrombosis, or severe vascular pathology on the relevant side\n* Conditions likely to significantly impair the reliability of thermodilution measurements (e.g., severe tricuspid regurgitation or significant intracardiac shunt)\n* Major treatment changes during the fluid challenge that preclude comparable measurements (e.g., major vasopressor dose change, major ventilator setting change, new arrhythmia)\n* Missing or inadequate data judged by the investigators to compromise data integrity, including absence of measurements required for the primary outcome","ALL","18 Years",{"count":51,"type":21},100,"This prospective single-center observational study aims to evaluate whether the ultrasound-measured femoral vein-to-femoral artery diameter ratio can predict fluid responsiveness in mechanically ventilated adult intensive care patients with acute circulatory failure or shock. Only patients who already have PiCCO monitoring as part of routine clinical care and for whom a fluid challenge is clinically indicated will be included. No additional invasive procedure will be performed for study purposes. Cardiac index will be measured with PiCCO before and after administration of 500 mL balanced crystalloid over 10 minutes, and femoral vein and femoral artery diameters will be measured by bedside ultrasonography. Fluid responsiveness will be defined as an increase of more than 10% in cardiac index after fluid administration. The study will assess the diagnostic performance of the femoral vein-to-femoral artery diameter ratio as a practical bedside parameter to support hemodynamic decision-making in critically ill patients.",[27,54,55],"Acute Circulatory Failure","Shock",[27,55,54,57,58,59,60,61],"Hemodynamic Monitoring","Ultrasonography","Femoral Vein","Femoral Artery","PiCCO","2026-05-07",{"date":64,"type":32},"2026-05-11",{"date":66,"type":32},"2026-05-01",{"date":68,"type":21},"2027-03-01",{"name":70,"class":39},"Istanbul University - Cerrahpasa",{"id":72,"slug":73,"hasResults":11,"nctId":74,"briefTitle":75,"officialTitle":75,"acronym":76,"eligibilityCriteria":77,"healthyVolunteers":11,"sex":48,"minAge":49,"maxAge":4,"enrollmentInfo":78,"targetDuration":4,"studyType":80,"phases":81,"briefSummary":83,"conditions":84,"keywords":89,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":98,"completionDateStruct":100,"leadSponsor":102,"locationsCount":40},"100593686","fluid-management-and-individualized-resuscitation-in-sepsis-100593686","NCT07009665","Fluid Management and Individualized Resuscitation in Sepsis","FLUIDS","Inclusion Criteria:\n\n* Adult patients (≥ 18 years of age);\n* Referred to internal medicine, nephrology, geriatric medicine, oncology, hematology, lung medicine, rheumatology, gastrointestinal \u002F liver medicine, urology, or emergency medicine (non-trauma);\n* Confirmed or suspected infection according to the physician's judgement upon arrival to the ED, based the presence of an acute phase response not due to an alternative non-infectious cause (i.e., body temperature \\\u003C 36°C or \\>38°C, leukocyte count \\> 12 x109\u002FL or C-reactive protein \\> 50 mg\u002FL), and\u002For on symptoms suggestive for an infection (e.g. productive cough, dyspnea, dysuria, pollakisuria, abdominal pain, erythema)\n* Need for hemodynamic resuscitation, based on any of the following (first measurement at ED arrival \\[triage\\]):\n* Mean arterial pressure (MAP) \\\u003C 70 mmHg\n* Systolic blood pressure (SBP) \\\u003C 90 mmHg or a SBP decrease \\>40 mmHg\n* Lactate \\> 4.0 mmol\u002FL\n* Shock index\\* \\> 0.9\n* Enrolled in study within one hour after ED arrival\n\nExclusion Criteria:\n\n* Primary diagnosis of: acute cerebral vascular event, acute coronary syndrome, acute pulmonary edema, status asthmaticus, major cardiac arrhythmia, drug overdose, or injury from burn or trauma, diabetic ketoacidosis, hyper-osmolarity syndrome, pancreatitis\n* Known aortic insufficiency, aortic abnormalities, or intraventricular heart defect, such as ventral septal defect or atrial septal defect\n* Known advanced heart failure - meaning NYHA IV functional class HF, on waiting list for heart transplant, LVAD recipient or chronic inotrope use.\n* Known end-stage kidney disease (dialysis-dependent CKD stage 5 or eGFR \\\u003C15 mL\u002Fmin\u002F1.73 m²)\n* Decompensated liver cirrhosis at ED admission (e.g., ascites, hepatic encephalopathy, or variceal bleeding)\n* Hemodynamic instability due to active bleeding\n* Patient has received \\>1 liter of IV fluid prior to study randomization\n* Requires immediate surgery\n* Transfer from another hospital after initiation of therapy (a.o. referred by another hospital ICU) or another in-hospital setting\n* Pregnant women\n* Trauma patients\n* Suspected intra-abdominal hypertension, based on the presence of portal hypertension (i.e. presence of ascites due to liver cirrhosis, esophageal varices or as measured by Doppler ultrasound)\n* Inability to obtain IV access\n* Patient uncouples from treatment algorithm\n* Patient should be excluded based on the opinion of the Clinician\u002FInvestigator\n* Not able to commence treatment protocol within 1 hour after randomization\n* Potential ICU-admission unwanted by advanced care directive (e.g., limited life expectancy)",{"count":79,"type":21},188,"INTERVENTIONAL",[82],"NA","The goal of this clinical trial is to find out if a personalized treatment approach can improve care for people with sepsis in the emergency department (ED).\n\nSepsis is a life-threatening condition that happens when the body has an uncontrolled response to an infection. This can lead to low blood pressure, organ failure, and death if not treated quickly. Right now, most people with sepsis receive a standard amount of fluids to raise their blood pressure. But this one-size-fits-all approach can lead to fluid overload and other complications. Because each person responds differently, this study will test whether a more personalized treatment-based on how the heart responds to fluids-can lead to safer and more effective care.\n\nThe study will include 188 adults who come to the ED at the University Medical Centre Groningen (UMCG) with suspected sepsis in need of hemodynamic resuscitation. Everyone in the study will receive fluids to support their blood pressure.\n\nParticipants will be randomly assigned to one of two groups:\n\n* Personalized treatment group: Fluids and vasopressors (medications that raise blood pressure) will be given based on how the heart responds to each fluid dose. This response is measured using a non-invasive monitor that tracks stroke volume index (ΔSVI)-a measure of how much blood the heart pumps.\n* Standard care group: Fluids will be given based on current guidelines (30 milliliters per kilogram of body weight), as decided by the treating doctor.\n\nResearchers will compare how much fluid is given during the first 3 hours of care. They will also look at:\n\n* When and how much vasopressor medicine is used\n* How well blood pressure and circulation respond\n* Signs of organ recovery or damage\n* How long participants stay in the hospital\n* Any problems or side effects during treatment\n\nThe researchers hope that this personalized approach will lead to using less fluid, starting vasopressors earlier, and helping people with sepsis recover more safely and quickly.",[85,55,86,87,88,27],"Sepsis","Personalized Medicine","Emergency Medicine","Critical Care, Fluid Resuscitation",[85,55,90,91,92,93,94],"Personalized medicine","emergency medicine","critical care","fluid resuscitation","fluid responsiveness","2025-12-14",{"date":97,"type":32},"2025-12-19",{"date":99,"type":32},"2025-09-01",{"date":101,"type":21},"2026-12-01",{"name":103,"class":39},"University Medical Center Groningen",{"id":105,"slug":106,"hasResults":11,"nctId":107,"briefTitle":108,"officialTitle":109,"acronym":4,"eligibilityCriteria":110,"healthyVolunteers":11,"sex":48,"minAge":49,"maxAge":111,"enrollmentInfo":112,"targetDuration":4,"studyType":80,"phases":114,"briefSummary":115,"conditions":116,"keywords":121,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":137,"lastUpdatePostDateStruct":138,"startDateStruct":140,"completionDateStruct":142,"leadSponsor":144,"locationsCount":40},"100561711","hemodynamic-monitoring-and-fluid-responsiveness-in-venovenous-extracorporeal-membrane-oxygenation-vv-ecmo---hemodynamecmonitoring-vv-study-100561711","NCT06593717","Hemodynamic Monitoring and Fluid Responsiveness in Venovenous Extracorporeal Membrane Oxygenation (VV ECMO) - \"HemodynamECMOnitoring-VV Study\"","Validation of Techniques for Hemodynamic Monitoring and Prediction of Fluid Responsiveness in Patients Undergoing Venovenous Extracorporeal Membrane Oxygenation - A Prospective Diagnostic Accuracy Study (\"HemodynamECMOnitoring-VV Study\")","Inclusion Criteria:\n\n* Patient receiving VV-ECMO support\n* Age 18 - 75 years\n\nExclusion Criteria:\n\n* Pregnancy\n* Conditions not allowing for passive leg raising maneuvers, e.g. \"open abdomen\", known or suspected elevation of intracranial pressure, recent leg or spinal trauma or orthopedic conditions not permitting leg raising\n* Known ischemic or hemorrhagic stroke within 3 months prior to study enrollment.\n\nSuspicion of raised intracranial pressure is defined as pupil divergence (if not yet further clarified radiographically\u002Fneurologically\u002Fophthalmologically) or signs detected in routine computed tomography scans (compressed or elapsed basal cisterns or midline shift \\> 5 mm.","75 Years",{"count":113,"type":21},30,[82],"In extracorporeal membrane oxygenation (ECMO), blood is drawn out of the body via tubes, oxygenated in an artificial lung; and then pumped back into the blood vessels. This allows the supply of oxygen-rich blood to the organs (brain, heart, lungs, kidneys, liver, intestines, etc.) to be maintained.\n\nContinuous monitoring of cardiac function and circulatory status (blood pressure, blood flow to organs) is very important in intensive care medicine in order to control the administration of circulation-supporting medication and infusions. Various devices are routinely used for this task. However, in the specific situation of ECMO treatment, the measurements of these devices could be affected due to the artificial circulation; outside the body.\n\nThe purpose of this study is therefore to test the accuracy of different methods of circulation monitoring during ECMO treatment.",[117,118,119,120,57,27],"ECMO Treatment","ARDS","Pneumonia","Intensive Care",[122,123,118,124,125,57,27,126,127,128,129,130,131,132,133,134,135,136],"VV ECMO","Extracorporeal Membrane Oxygenation","Intensive Care Medicine","Critical Care Medicine","Passive Leg Raising","Pulse Contour Analysis","Transpulmonary Thermodilution","Bioreactance","Pulse Pressure Variation","End-expiratory Occlusion Test","End-inspiratory Occlusion Test","Cardiac Output","LVOT VTI","Stroke Volume","Vena Cava Ultrasound","2025-09-23",{"date":139,"type":32},"2025-09-29",{"date":141,"type":32},"2024-05-03",{"date":143,"type":21},"2027-01",{"name":145,"class":39},"Medical University of Vienna",{"id":147,"slug":148,"hasResults":11,"nctId":149,"briefTitle":150,"officialTitle":151,"acronym":4,"eligibilityCriteria":152,"healthyVolunteers":11,"sex":48,"minAge":49,"maxAge":111,"enrollmentInfo":153,"targetDuration":4,"studyType":80,"phases":154,"briefSummary":155,"conditions":156,"keywords":157,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":137,"lastUpdatePostDateStruct":158,"startDateStruct":159,"completionDateStruct":160,"leadSponsor":161,"locationsCount":40},"100561714","hemodynamic-monitoring-and-fluid-responsiveness-in-venoarterial-extracorporeal-membrane-oxygenation-va-ecmo---hemodynamecmonitoring-va-study-100561714","NCT06593756","Hemodynamic Monitoring and Fluid Responsiveness in Venoarterial Extracorporeal Membrane Oxygenation (VA ECMO) - \"HemodynamECMOnitoring-VA Study\"","Validation of Techniques for Hemodynamic Monitoring and Prediction of Fluid Responsiveness in Patients Undergoing Venoarterial Extracorporeal Membrane Oxygenation - A Prospective Diagnostic Accuracy Study (\"HemodynamECMOnitoring-VA Study\")","Inclusion Criteria:\n\n* Patient receiving VA ECMO support\n* Age 18 - 75 years\n\nExclusion Criteria:\n\n* Pregnancy\n* Conditions not allowing for passive leg raising maneuvers, e.g. \"open abdomen\", known or suspected elevation of intracranial pressure, recent leg or spinal trauma or orthopedic conditions not permitting leg raising\n* Known ischemic or hemorrhagic stroke within 3 months prior to study enrollment.",{"count":113,"type":21},[82],"In extracorporeal membrane oxygenation (ECMO), blood is drawn out of the body via tubes, oxygenated in an artificial lung; and then pumped back into the blood vessels. This allows the supply of oxygen-rich blood to the organs (brain, heart, lungs, kidneys, liver, intestines, etc.) to be maintained. Continuous monitoring of cardiac function and circulatory status (blood pressure, blood flow to organs) is very important in intensive care medicine in order to control the administration of circulation-supporting medication and infusions. Various devices are routinely used for this task. However, in the specific situation of ECMO treatment, the measurements of these devices could be affected due to the artificial circulation; outside the body. The purpose of this study is therefore to test the accuracy of different methods of circulation monitoring during ECMO treatment.",[117,118,119,120,57,27],[122,123,118,124,125,57,27,126,127,128,129,130,131,132,133,134,135,136],{"date":139,"type":32},{"date":141,"type":32},{"date":143,"type":21},{"name":145,"class":39},{"id":163,"slug":164,"hasResults":11,"nctId":165,"briefTitle":166,"officialTitle":167,"acronym":168,"eligibilityCriteria":169,"healthyVolunteers":11,"sex":48,"minAge":49,"maxAge":170,"enrollmentInfo":171,"targetDuration":173,"studyType":22,"phases":4,"briefSummary":174,"conditions":175,"keywords":4,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":179,"lastUpdatePostDateStruct":180,"startDateStruct":182,"completionDateStruct":184,"leadSponsor":186,"locationsCount":188},"100575419","fluid-responsiveness-and-venous-congestion-evolution-during-volume-expansion-100575419","NCT06772038","Fluid Responsiveness and Venous Congestion Evolution During Volume Expansion","Dynamic Assessment of Fluid Responsiveness and Venous Congestion: Evolution of the VExUS Score During Volume Expansion","FREVO","Inclusion Criteria:\n\n* Age ≥ 18 years\n* Hospitalized in the intensive care unit (ICU)\n* Hemodynamic monitoring in place, with a pulse wave contour analysis- derived estimation of cardiac output (either calibrated or uncalibrated)\n* Decision made by clinicians to perform volume expansion through intravenous infusion of crystalloid fluid\n\nExclusion Criteria:\n\n* Pregnancy\n* Refusal to participate by relatives of the patient or the patient himself","99 Years",{"count":172,"type":21},64,"1 Month","Fluid responsiveness is a critical determinant guiding fluid therapy in critically ill patients. However, excessive fluid administration can result in fluid overload, leading to venous congestion and worse clinical outcomes. Venous congestion, a marker of impaired fluid clearance, is increasingly recognized as a significant contributor to poor prognosis. Previous studies have demonstrated the coexistence of fluid responsiveness and venous congestion in critically ill patients. Notably, these studies were limited by the absence of fluid challenge-the gold standard for assessing fluid responsiveness-leaving the dynamic relationship between fluid responsiveness and venous congestion incompletely understood. This study aims to investigate the interplay and temporal evolution of fluid responsiveness and venous congestion following a standardized fluid challenge in critically ill patients.",[176,27,177,178],"Hemodynamic","Venous Congestion","Fluid Challenge","2025-01-08",{"date":181,"type":32},"2025-01-13",{"date":183,"type":21},"2025-01-05",{"date":185,"type":21},"2025-07-30",{"name":187,"class":39},"Bicetre Hospital",3,{"id":190,"slug":191,"hasResults":11,"nctId":192,"briefTitle":193,"officialTitle":194,"acronym":195,"eligibilityCriteria":196,"healthyVolunteers":11,"sex":48,"minAge":197,"maxAge":198,"enrollmentInfo":199,"targetDuration":4,"studyType":22,"phases":4,"briefSummary":200,"conditions":201,"keywords":202,"overallStatus":28,"whyStopped":4,"lastUpdateSubmitDate":206,"lastUpdatePostDateStruct":207,"startDateStruct":209,"completionDateStruct":211,"leadSponsor":213,"locationsCount":40},"100546091","passive-leg-raise-and-mini-fluid-challenge-effect-on-various-cardiac-output-surrogates-for-fluid-responsiveness-100546091","NCT06390423","Passive Leg Raise and Mini-fluid Challenge Effect on Various Cardiac Output Surrogates for Fluid Responsiveness","Passive Leg Raise and Mini-fluid Challenge Effect on Various Cardiac Output Surrogates Such as Pulse Pressure Variation (PPV), End-tidal CO2 (Carbon Dioxide), Bioreactance (Stroke Volume Index -SVI) and Velocity Time Integral on Echocardiographic Exam for Fluid Responsiveness in Patients With Moderately Severe ARDS (Acute Respiratory Distress Syndrome)","PHOENIX","Inclusion Criteria:\n\n* Age between 30 - 90 years\n* Diagnosis of Vasodilatory Shock with no other obvious cause of hypotension\n* Diagnosis of ARDS with PF ratio \\\u003C 150 , PEEP \\> 8\n* Patients who are under paralysis or deeply sedated, on a mechanical ventilator\n\nExclusion Criteria:\n\n* Patients with arrhythmias including atrial fibrillation\n* Patients with chest tube, intra-abdominal hypertension or with its risk factors\n* Patients with structural heart disease including pulmonary hypertension (RVSP \\> 45) and heart failure\n* Patients on extracorporeal support such as ECMO, CRRT or MCS.\n* Patients with COPD with a premorbid FEV1 \\\u003C 1.5 L\n* Severe atherosclerotic vascular disease","30 Years","90 Years",{"count":172,"type":21},"In the critically ill population, fluid administration in an unstable patient is perhaps the most common intervention that is performed. Uncorrected hypovolemia with inappropriate vasopressors lead to organ hypoperfusion where as overzealous fluid administration especially in ARDS (Adult respiratory distress syndrome) can increase mortality. It has been estimated that only 50% of hemodynamically unstable critically ill patients are volume responsive, hence dynamic assessment of preload responsiveness has been proposed to better identify those individuals who would benefit from fluid bolus.",[27],[203,204,205],"Pre-load responsiveness","Passive leg raise","Mini-fluid challenge","2024-08-20",{"date":208,"type":32},"2024-08-22",{"date":210,"type":32},"2023-07-01",{"date":212,"type":21},"2025-06",{"name":214,"class":39},"CentraCare",{"id":216,"slug":217,"hasResults":11,"nctId":218,"briefTitle":219,"officialTitle":220,"acronym":4,"eligibilityCriteria":221,"healthyVolunteers":11,"sex":48,"minAge":49,"maxAge":4,"enrollmentInfo":222,"targetDuration":4,"studyType":80,"phases":224,"briefSummary":225,"conditions":226,"keywords":227,"overallStatus":229,"whyStopped":4,"lastUpdateSubmitDate":230,"lastUpdatePostDateStruct":231,"startDateStruct":233,"completionDateStruct":235,"leadSponsor":237,"locationsCount":4},"100535640","fluid-responsiveness-in-prone-patients-100535640","NCT06254456","Fluid Responsiveness in Prone Patients","End Expiratory Occlusion Test and Tidal Volume Challenge Test for Assess Fluid Responsiveness in Prone Patients","Inclusion Criteria:\n\n* patients planed to prone position for treatment\n\nExclusion Criteria:\n\n* no consent\n* arrhythmia\n* pregnancy\n* pre existing pneumothorax\n* pre existing fluid overload\n* cannot insert arterial or central venous catheters",{"count":223,"type":21},84,[82],"To assess fluid responsiveness in prone patient",[27],[228],"Fluid responsiveness, prone, EEOT, TVC, ARDS","NOT_YET_RECRUITING","2024-02-03",{"date":232,"type":32},"2024-02-12",{"date":234,"type":21},"2024-03-01",{"date":236,"type":21},"2028-07-04",{"name":238,"class":39},"Bhumibol Adulyadej Hospital"]